An enlarged prostate, known medically as benign prostatic hyperplasia (BPH), is driven by a combination of hormonal changes and genetic predisposition. The condition develops when prostate cells multiply faster than they die, and both testosterone-related hormones and inherited genes play direct roles in that process. While age is the strongest single risk factor, the hormones dihydrotestosterone (DHT) and estrogen, along with specific genetic variations, determine who actually develops the condition and how severe it becomes.
What Causes An Enlarged Prostate Hormones To Genes?
The short answer is that an enlarged prostate happens when normal hormonal signals go slightly out of balance with age, and some men inherit genes that make their prostate tissue more sensitive to those signals. The hormone DHT, which is made from testosterone, is the main driver of prostate cell growth. As men age, testosterone levels fall but DHT levels in prostate tissue often stay steady, which keeps the growth signal switched on. At the same time, estrogen levels rise relative to testosterone, and this shift also promotes prostate cell multiplication.
Genetics matter too. Studies of families and twins show that BPH runs in families. If your father or brother had significant prostate enlargement, your own risk is measurably higher. Researchers have identified several gene variants linked to prostate growth, though no single “BPH gene” exists. It is a polygenic condition, meaning many small genetic differences add up.
How Does DHT Actually Cause Prostate Growth?
DHT binds to androgen receptors inside prostate cells. Once bound, it travels into the cell nucleus and turns on genes that instruct the cell to divide. This is not a subtle process — DHT is roughly ten times more powerful than testosterone at activating these receptors.
Prostate tissue contains an enzyme called 5-alpha-reductase, which converts testosterone into DHT. This enzyme exists in two forms, type 1 and type 2. The type 2 form is most active in the prostate. This matters because medications called 5-alpha-reductase inhibitors, such as finasteride and dutasteride, work by blocking this enzyme. When DHT production drops, prostate cell growth slows, and the gland can shrink by about 20-30 percent in many men.
The key insight is that DHT is not harmful by itself. It is essential for normal prostate development in puberty. The problem is that decades of continuous DHT exposure, combined with age-related changes in how prostate cells respond to growth signals, tips the balance toward excess tissue.
What Role Do Estrogen and Testosterone Play?
As men age, total testosterone levels decline by roughly 1-2 percent per year after age 40. Meanwhile, estrogen levels stay the same or rise slightly because testosterone is converted into estrogen by an enzyme called aromatase, which becomes more active in fat tissue and the prostate itself.
This changing ratio matters. Estrogen receptors exist in prostate tissue, and estrogen can directly stimulate prostate cell growth. More importantly, estrogen may make prostate cells more sensitive to DHT. Some research suggests that estrogen increases the number of androgen receptors on prostate cells, meaning even normal DHT levels produce a stronger growth response.
This hormonal shift also explains why prostate growth is a gradual process. It is not a sudden event but a slow accumulation over decades. By age 60, about 50 percent of men have some prostate enlargement. By age 85, that figure rises to roughly 90 percent.
Can Genetics Predict Prostate Enlargement?
Genetic research on BPH has identified several relevant genes, but the picture is incomplete. Some studies have linked variants in the SRD5A2 gene, which codes for the 5-alpha-reductase enzyme, to altered DHT production. Other research has examined genes involved in inflammation, growth factors, and hormone receptors.
The strongest genetic evidence comes from family and twin studies. A man with a first-degree relative who had BPH surgery is more likely to need surgery himself. Twin studies show that identical twins have more similar prostate volumes than fraternal twins, confirming a substantial inherited component.
However, knowing your genetic risk does not currently change clinical care. There is no approved genetic test for BPH risk. Doctors diagnose BPH based on symptoms, prostate size on examination or ultrasound, and urine flow measurements — not genetic testing.
Are There Other Contributing Factors Beyond Hormones and Genes?
Hormones and genes set the stage, but other factors influence whether a man develops symptoms. Chronic inflammation in the prostate is one area of active research. Some studies have found inflammatory cells in prostate tissue from men with BPH, and inflammation may stimulate growth factors that promote cell division.
Metabolic factors also appear relevant. Men with obesity, diabetes, or metabolic syndrome tend to have larger prostates and more rapid growth. This may connect back to hormones, since fat tissue produces estrogen and contributes to the estrogen-testosterone imbalance described above.
Lifestyle factors such as diet and exercise have been studied, but the evidence is less certain. Some research suggests that physical activity is associated with a lower risk of BPH, possibly through effects on inflammation and hormone levels. No specific diet has been proven to prevent prostate enlargement.
What Are the Symptoms of an Enlarged Prostate?
Symptoms arise because the prostate surrounds the urethra, the tube that carries urine out of the bladder. As the gland grows, it can compress the urethra and partially block urine flow. The bladder then has to work harder to push urine out, which over time can weaken the bladder muscle.
Common symptoms include:
- Weak or interrupted urine stream
- Difficulty starting urination
- Frequent urination, especially at night
- Urgent need to urinate
- Feeling that the bladder is not completely empty
- Dribbling after urination
These symptoms are scored using a standardized questionnaire called the International Prostate Symptom Score. This tool helps doctors determine whether symptoms are mild, moderate, or severe, which guides treatment decisions.
How Is Enlarged Prostate Treated?
Treatment depends on symptom severity and how much the condition affects quality of life. For mild symptoms, many doctors recommend watchful waiting with regular monitoring. Lifestyle changes such as reducing evening fluid intake and limiting caffeine and alcohol may help some men.
Medication options fall into two main classes. Alpha-blockers such as tamsulosin relax the smooth muscle in the prostate and bladder neck, improving urine flow. These work quickly, often within days, but do not shrink the prostate. 5-alpha-reductase inhibitors such as finasteride and dutasteride reduce DHT production and can shrink the prostate over several months. These are most effective for men with larger prostates.
For men with moderate to severe symptoms who do not respond to medication, surgical options exist. The most common procedure is transurethral resection of the prostate, or TURP, which removes excess prostate tissue through the urethra. Newer minimally invasive techniques use water vapor, lasers, or specialized implants to reduce prostate volume with fewer side effects.
No treatment is risk-free, and none is right for everyone. A urologist can help match treatment options to your specific symptoms, prostate size, and overall health.
Can Prostate Enlargement Be Prevented?
No intervention has been proven to prevent BPH entirely. The condition is so common with age that it is arguably a normal part of male aging rather than a disease that can be fully avoided.
That said, some evidence suggests that maintaining a healthy weight and staying physically active may reduce risk or slow progression. These habits also improve overall health, so they are worth adopting regardless of prostate status.
Regular checkups matter. An enlarged prostate shares some symptoms with prostate cancer, though the two conditions are not the same and one does not cause the other. If you notice changes in urination, a doctor can evaluate whether the cause is BPH, prostate cancer, or another condition entirely.
Frequently Asked Questions
Can an enlarged prostate turn into prostate cancer?
No. BPH is a non-cancerous condition and does not become prostate cancer.
However, a man can have both BPH and prostate cancer at the same time, which is why persistent urinary symptoms should always be evaluated by a doctor.
Does having an enlarged prostate affect testosterone levels?
No, an enlarged prostate does not cause low testosterone.
The hormonal changes that contribute to BPH happen inside the prostate tissue itself and do not necessarily show up in blood tests for total testosterone.
Is an enlarged prostate hereditary?
Yes, genetics play a significant role.
Men with a father or brother who had significant BPH are more likely to develop it themselves, though no single gene determines the outcome.
At what age does prostate enlargement usually begin?
Prostate growth typically begins after age 40.
Symptoms most often appear between ages 50 and 60, and the prevalence continues to rise with each decade of life.
